• Mon, June 17, 2019
  • Tue, June 18, 2019
  • Wed, June 19, 2019
  • Thu, June 20, 2019
  • Fri, June 21, 2019

Matthew Luchini Maintained (BLUE) at Buy with Decreased Target to $163 on, Jun 17th, 2019

Matthew Luchini of BMO Capital, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $191 to $163 on, Jun 17th, 2019.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Tuesday, March 5th, 2019


This is the rating of the analyst that currently disagrees with Matthew


  • Yaron Werber of "Cowen & Co." Initiated at Buy on, Tuesday, February 26th, 2019